Ratings by Leerink Partners (Puneet Souda)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/2/2026 | Twist Bioscience | TWST | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/27/2026 | 10X Genomics | TXG | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/12/2026 | Veracyte, Inc | VCYT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/25/2025 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 11/20/2025 | Exact Sciences | EXAS | Downgrade | Market Perform (Outperform) |
86.18 (103.50) |
20.1% | Details | |
| 10/28/2025 | Neogenomics | NEO | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/25/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2025 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2025 | CryoPort | CYRX | Upgrade | Outperform (Market Perform) |
6.74 (8.09) |
20.03% | Details | |
| 8/5/2025 | 908 Devices Inc. | MASS | Upgrade | Outperform (Market Perform) |
0.00 (6.26) |
0% | Details | |
| 6/27/2025 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/4/2025 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2025 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/29/2025 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2025 | Twist Bioscience | TWST | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/2/2025 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2025 | Quanterix Corp. | QTRX | Maintain | Market Perform (Outperform) |
|
Details | ||
| 4/30/2025 | Neogenomics | NEO | Downgrade | Market Perform (Outperform) |
9.97 (8.96) |
-10.13% | Details | |
| 3/6/2025 | Waters Corp. | WAT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2025 | 908 Devices Inc. | MASS | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/4/2025 | Repligen | RGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/4/2025 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2025 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2025 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/13/2025 | 10X Genomics | TXG | Downgrade | Market Perform (Outperform) |
12.00 (20.81) |
73.42% | Details | |
| 2/7/2025 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2025 | Hologic | HOLX | Downgrade | Market Perform (Outperform) |
72.80 (75.74) |
4.04% | Details | |
| 12/9/2024 | Myriad Genetics | MYGN | Downgrade | Market Perform (Outperform) |
15.13 (5.15) |
-65.96% | Details | |
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2024 | 908 Devices Inc. | MASS | Downgrade | Market Perform (Outperform) |
2.92 (6.26) |
114.38% | Details | |
| 11/7/2024 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2024 | Danaher | DHR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/11/2024 | Myriad Genetics | MYGN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/9/2024 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/4/2024 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2024 | 10X Genomics | TXG | New Coverage | Outperform (N/A) |
23.35 (20.81) |
-10.88% | Details | |
| 8/1/2024 | Waters Corp. | WAT | Upgrade | Outperform (Market Perform) |
336.28 (302.54) |
-10.03% | Details | |
| 5/20/2024 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2024 | Myriad Genetics | MYGN | Upgrade | Outperform (Market Perform) |
19.78 (5.15) |
-73.96% | Details | |
| 10/18/2023 | Olink Holding AB | OLK | Downgrade | Market Perform (Outperform) |
14.98 (26.08) |
74.1% | Details | |
| 8/30/2023 | Abcam Plc. | ABCM | Downgrade | Market Perform (Outperform) |
22.35 (23.99) |
7.34% | Details | |
| 8/8/2023 | Quanterix Corp. | QTRX | Upgrade | (N/A) |
21.73 (5.06) |
-76.71% | Details | |
| 7/13/2023 | CryoPort | CYRX | Downgrade | Market Perform (Outperform) |
19.40 (8.09) |
-58.3% | Details | |
| 6/20/2023 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2023 | Danaher | DHR | New Coverage | Outperform (N/A) |
236.91 (195.50) |
-17.48% | Details | |
| 10/4/2022 | Illumina | ILMN | Upgrade | Outperform (Market Perform) |
187.24 (124.62) |
-33.44% | Details | |
| 8/11/2022 | IsoPlexis Corp | ISO | Downgrade | Market Perform (Outperform) |
3.00 (0.76) |
-74.67% | Details | |
| 8/10/2022 | Invitae Corporation | NVTA | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/3/2022 | Repligen | RGEN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/19/2022 | Invitae Corporation | NVTA | Downgrade | Market Perform (Outperform) |
2.67 (0.02) |
-99.25% | Details | |
| 2/1/2022 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/19/2021 | Illumina | ILMN | Downgrade | Market Perform (Outperform) |
510.61 (187.24) |
-63.33% | Details | |
| 6/21/2021 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2021 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2021 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2021 | Thermo Fisher Scientific | TMO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/19/2021 | Olink Holding AB | OLK | New Coverage | Outperform (N/A) |
37.50 (26.08) |
-30.45% | Details | |
| 2/17/2021 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2021 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2021 | AbCellera Biologics | ABCL | New Coverage | Outperform (N/A) |
39.10 (3.80) |
-90.28% | Details | |
| 11/6/2020 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2020 | T2 Biosystems, Inc | TTOO | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2020 | Veracyte, Inc | VCYT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2020 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/22/2020 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2020 | Natera | NTRA | New Coverage | Outperform (N/A) |
61.15 (198.13) |
224.01% | Details | |
| 8/19/2020 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2020 | T2 Biosystems, Inc | TTOO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2020 | Castle Biosciences | CSTL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2020 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2020 | Veracyte, Inc | VCYT | Maintain | Outperform (N/A) |
|
Details | ||
| 7/29/2020 | Waters Corp. | WAT | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/23/2020 | Thermo Fisher Scientific | TMO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | T2 Biosystems, Inc | TTOO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Invitae Corporation | NVTA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/29/2020 | Waters Corp. | WAT | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/29/2020 | Neogenomics | NEO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2020 | Centogene NV | CNTG | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Veracyte, Inc | VCYT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/30/2020 | Castle Biosciences | CSTL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2020 | HTG Molecular Diagnostics | HTGM | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2020 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/19/2020 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2020 | Myriad Genetics | MYGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/6/2020 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/2/2019 | Centogene NV | CNTG | New Coverage | Outperform (N/A) |
12.97 (0.33) |
-97.46% | Details | |
| 11/5/2019 | Myriad Genetics | MYGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/30/2019 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2019 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/15/2019 | Repligen | RGEN | New Coverage | Outperform (N/A) |
77.25 (119.99) |
55.33% | Details | |
| 9/26/2019 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/24/2019 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2019 | T2 Biosystems, Inc | TTOO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2019 | Castlight | CSTL | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | T2 Biosystems, Inc | TTOO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/31/2019 | Neogenomics | NEO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2019 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 7/15/2019 | CryoPort | CYRX | New Coverage | Outperform (N/A) |
19.59 (8.09) |
-58.7% | Details | |
| 6/21/2019 | Bruker | BRKR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2019 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2019 | Bruker | BRKR | Upgrade | Outperform (Market Perform) |
38.10 (36.68) |
-3.73% | Details | |
| 4/24/2019 | Thermo Fisher Scientific | TMO | Maintain | Outperform (N/A) |
|
Details | ||
| 1/30/2019 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/29/2018 | Guardant Health | GH | New Coverage | Outperform (N/A) |
35.14 (91.20) |
159.53% | Details | |
| 10/19/2018 | Illumina | ILMN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2018 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2018 | Waters Corp. | WAT | Downgrade | Market Perform (Outperform) |
191.33 (302.54) |
58.12% | Details | |
| 9/10/2018 | Bio-Techne Corp. | TECH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/28/2018 | Myriad Genetics | MYGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/23/2018 | Exact Sciences | EXAS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/21/2018 | Neogenomics | NEO | New Coverage | Outperform (N/A) |
12.67 (8.96) |
-29.28% | Details |
